Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.73B |
| 2 |
Tesla
TSLA
|
+$1.4B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.35B |
| 4 |
Altria Group
MO
|
+$1.19B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$777M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$1.42B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.3B |
| 3 |
Uber
UBER
|
+$1.25B |
| 4 |
RTX Corp
RTX
|
+$1.08B |
| 5 |
Danaher
DHR
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.3% |
| 2 | Technology | 21.37% |
| 3 | Financials | 10.81% |
| 4 | Healthcare | 9.76% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Analog Devices
ADI
$175B
| $1.36B | 0.11% |
6,859,669
+229,240
| +3% | +$44.1M |
|
177
Equifax
EFX
$19.9B
| $1.35B | 0.11% |
5,055,548
-369,995
| -7% | -$94.2M |
|
178
iShares Core S&P US Growth ETF
IUSG
$33B
| $1.35B | 0.11% |
11,515,758
+231,138
| +2% | +$25.7M |
|
179
Royalty Pharma
RPRX
$26.3B
| $1.34B | 0.11% |
44,217,885
-2,136,381
| -5% | -$63M |
|
180
iShares MSCI USA Quality Factor ETF
QUAL
$46.9B
| $1.34B | 0.11% |
8,150,997
+280,218
| +4% | +$43.8M |
|
181
Vertex Pharmaceuticals
VRTX
$132B
| $1.33B | 0.11% |
3,184,466
+204,011
| +7% | +$86.2M |
|
182
TransDigm Group
TDG
$61.4B
| $1.33B | 0.11% |
1,079,215
+53,652
| +5% | +$60.4M |
|
183
Gilead Sciences
GILD
$182B
| $1.32B | 0.11% |
18,013,584
+211,866
| +1% | +$16.3M |
|
184
O'Reilly Automotive
ORLY
$70.6B
| $1.32B | 0.11% |
17,527,395
-1,161,945
| -6% | -$81.3M |
|
185
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47B
| $1.32B | 0.11% |
14,341,028
-1,105,141
| -7% | -$101M |
|
186
McKesson
MCK
$103B
| $1.3B | 0.1% |
2,429,354
-86,276
| -3% | -$43.8M |
|
187
Carvana
CVNA
$51B
| $1.29B | 0.1% |
73,564,020
-11,184,495
| -13% | -$137M |
|
188
Regeneron Pharmaceuticals
REGN
$80.5B
| $1.29B | 0.1% |
1,339,499
+199,980
| +18% | +$190M |
|
189
Otis Worldwide
OTIS
$26.3B
| $1.29B | 0.1% |
12,972,821
+235,459
| +2% | +$21.8M |
|
190
Chipotle Mexican Grill
CMG
$46.9B
| $1.28B | 0.1% |
21,943,650
+413,250
| +2% | +$21.1M |
|
191
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
| $1.26B | 0.1% |
21,753,308
+1,730,962
| +9% | +$101M |
|
192
iShares Russell Mid-Cap Growth ETF
IWP
$19.2B
| $1.26B | 0.1% |
11,023,819
+93,349
| +0.9% | +$10.1M |
|
193
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.5B
| $1.26B | 0.1% |
24,800,166
+156,250
| +0.6% | +$7.53M |
|
194
Vanguard FTSE All-World ex-US ETF
VEU
$69.4B
| $1.25B | 0.1% |
21,337,367
-1,479,457
| -6% | -$83.6M |
|
|
MRSH
195
Marsh
MRSH
$84.4B
| $1.25B | 0.1% |
6,070,102
-16,492
| -0.3% | -$3.29M |
|
196
Broadridge
BR
$19.1B
| $1.23B | 0.1% |
6,017,077
-169,460
| -3% | -$34.2M |
|
197
Boston Scientific
BSX
$65.3B
| $1.23B | 0.1% |
17,964,783
-796,798
| -4% | -$51.2M |
|
198
Trip.com Group
TCOM
$24.6B
| $1.23B | 0.1% |
27,951,366
+2,857,487
| +11% | +$116M |
|
199
iShares Core S&P Total US Stock Market ETF
ITOT
$95.8B
| $1.23B | 0.1% |
10,626,690
-134,588
| -1% | -$14.8M |
|
200
Illinois Tool Works
ITW
$76.6B
| $1.22B | 0.1% |
4,561,604
+86,743
| +2% | +$22.5M |
|
Similar funds
Morgan Stanley's Q1 2024 Portfolio in Review
As of Q1 2024, Morgan Stanley held 8,146 positions worth $1.25T, up 9.8% from $1.13T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Morgan Stanley's Q1 2024 filing shows 340 new, 3,230 increased, 3,352 reduced and 318 closed positions. Its largest new stake was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M. The largest sale was Philip Morris, an estimated $1.42B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q1 2024 buy was Grayscale Bitcoin Trust: 4,729,259 shares worth $270M.
- Morgan Stanley added most to UnitedHealth in Q1 2024, an estimated $1.73B increase.
- Morgan Stanley's biggest Q1 2024 reduction was Philip Morris, cutting an estimated $1.42B.
- Morgan Stanley fully exited Mirati Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $362M.
- Morgan Stanley's ten largest holdings make up 19% of its $1.25T portfolio in Q1 2024.
- Morgan Stanley opened 340 new positions and closed 318 in Q1 2024.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.25T.
Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.